SeaCrest Wealth Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-700
Closed -$17K 2183
2018
Q4
$17K Buy
+700
New +$18.8K ﹤0.01% 1296

Other funds holding IRMD

SeaCrest Wealth Management's IRMD Position: Q1 2019 in Review

SeaCrest Wealth Management sold out of iRadimed (IRMD) in Q1 2019, closing a stake of 700 shares — an estimated $17K sold.

SeaCrest Wealth Management first reported a position in IRMD in Q4 2018 and held it in 1 quarter. The position peaked at $17K in Q4 2018. 64 funds tracked by Wall St. Rank hold IRMD as of Q1 2019.

  • SeaCrest Wealth Management reported no remaining iRadimed position as of Q1 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 700 iRadimed shares in Q1 2019, an estimated $17K.
  • SeaCrest Wealth Management first reported a position in iRadimed in Q4 2018 and held it in 1 quarter.
  • SeaCrest Wealth Management's iRadimed position peaked at $17K in Q4 2018.
  • 64 funds tracked by Wall St. Rank held iRadimed as of Q1 2019.

Based on SeaCrest Wealth Management's 13F filing for Q1 2019, filed 10 May 2019.